GI heptapeptide
- Generic Name
- GI heptapeptide
- Drug Type
- Biotech
- Unique Ingredient Identifier
- D33CAJ796A
- Background
GI heptapeptide is under investigation in clinical trial NCT01391208 (Esophageal Protocol for Detection of Neoplasia in the Digestive Tract).
A In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
- First Posted Date
- 2012-06-28
- Last Posted Date
- 2015-10-08
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 60
- Registration Number
- NCT01630798
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
Phase 1
Completed
- Conditions
- Barrett EsophagusEsophageal Adenocarcinoma
- Interventions
- First Posted Date
- 2011-07-11
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 25
- Registration Number
- NCT01391208
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath